Tech Center 1600 • Art Units: 1642 1643 1644
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18491249 | COMPOSITIONS AND METHODS USED FOR RETINAL ISCHEMIA OR DIABETES | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18289836 | Targeting Extracellular Matrix Proteins to Regulate NK Cell Function in Peripheral Tissues | Non-Final OA | The General Hospital Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy